247 related articles for article (PubMed ID: 32039436)
21. Safety and efficacy of anti-tumor necrosis factor α therapy in ten patients with recent-onset refractory reactive arthritis.
Meyer A; Chatelus E; Wendling D; Berthelot JM; Dernis E; Houvenagel E; Morel J; Richer O; Schaeverbeke T; Gottenberg JE; Sibilia J;
Arthritis Rheum; 2011 May; 63(5):1274-80. PubMed ID: 21538314
[TBL] [Abstract][Full Text] [Related]
22. Reactive arthritis induced by intravesical BCG therapy for bladder cancer: our clinical experience and systematic review of the literature.
Bernini L; Manzini CU; Giuggioli D; Sebastiani M; Ferri C
Autoimmun Rev; 2013 Oct; 12(12):1150-9. PubMed ID: 23816569
[TBL] [Abstract][Full Text] [Related]
23. Reactive arthritis.
Leirisalo-Repo M
Scand J Rheumatol; 2005; 34(4):251-9. PubMed ID: 16195157
[TBL] [Abstract][Full Text] [Related]
24. Reactive arthritis after SARS-CoV-2 infection.
Dombret S; Skapenko A; Schulze-Koops H
RMD Open; 2022 Sep; 8(2):. PubMed ID: 36096524
[TBL] [Abstract][Full Text] [Related]
25. [Reactive arthritis: advances in diagnosis and treatment].
Palazzi C; Olivieri I; Salvarani C; D'Amico E; Alleva G; Vitullo P; Petricca A
Reumatismo; 2002; 54(2):105-12. PubMed ID: 12105678
[TBL] [Abstract][Full Text] [Related]
26. Knowledge and Perceptions of Reactive Arthritis Diagnosis and Management Among Healthcare Workers During the COVID-19 Pandemic: Online Survey.
Bekaryssova D; Joshi M; Gupta L; Yessirkepov M; Gupta P; Zimba O; Gasparyan AY; Ahmed S; Kitas GD; Agarwal V
J Korean Med Sci; 2022 Dec; 37(50):e355. PubMed ID: 36573387
[TBL] [Abstract][Full Text] [Related]
27. Reactive arthritis: defined etiologies, emerging pathophysiology, and unresolved treatment.
Carter JD
Infect Dis Clin North Am; 2006 Dec; 20(4):827-47. PubMed ID: 17118292
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological treatment of psoriatic arthritis: a systematic literature research for the 2019 update of the EULAR recommendations for the management of psoriatic arthritis.
Kerschbaumer A; Smolen JS; Dougados M; de Wit M; Primdahl J; McInnes I; van der Heijde D; Baraliakos X; Falzon L; Gossec L
Ann Rheum Dis; 2020 Jun; 79(6):778-786. PubMed ID: 32381564
[TBL] [Abstract][Full Text] [Related]
29. Rheumatoid arthritis.
Lorenzo M
Foot Ankle Clin; 2007 Sep; 12(3):525-37, vii. PubMed ID: 17765843
[TBL] [Abstract][Full Text] [Related]
30. Reactive arthritis.
Hannu T
Best Pract Res Clin Rheumatol; 2011 Jun; 25(3):347-57. PubMed ID: 22100285
[TBL] [Abstract][Full Text] [Related]
31. Bacteria-Triggered reactive arthritis: implications for antibacterial treatment.
Toivanen A
Drugs; 2001; 61(3):343-51. PubMed ID: 11293645
[TBL] [Abstract][Full Text] [Related]
32. Clostridium difficile associated reactive arthritis: Case report and literature review.
Legendre P; Lalande V; Eckert C; Barbut F; Fardet L; Meynard JL; Surgers L
Anaerobe; 2016 Apr; 38():76-80. PubMed ID: 26743187
[TBL] [Abstract][Full Text] [Related]
33. New Approaches in Tumor Necrosis Factor Antagonism for the Treatment of Psoriatic Arthritis: Certolizumab Pegol.
Cauli A; Piga M; Lubrano E; Marchesoni A; Floris A; Mathieu A
J Rheumatol Suppl; 2015 Nov; 93():70-2. PubMed ID: 26523062
[TBL] [Abstract][Full Text] [Related]
34. Reactive arthritis responding to antiretroviral therapy in an HIV-1-infected individual.
Scott C; Brand A; Natha M
Int J STD AIDS; 2012 May; 23(5):373-4. PubMed ID: 22648898
[TBL] [Abstract][Full Text] [Related]
35. Reactive arthritis.
Svenungsson B
Int J STD AIDS; 1995; 6(3):156-60. PubMed ID: 7647116
[TBL] [Abstract][Full Text] [Related]
36. A bicentre retrospective study of features and outcomes of patients with reactive arthritis.
Courcoul A; Brinster A; Decullier E; Larbre JP; Piperno M; Pradat E; Tebib JG; Wendling D; Coury F
Joint Bone Spine; 2018 Mar; 85(2):201-205. PubMed ID: 28238883
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic strategies in psoriasis patients with psoriatic arthritis: focus on new agents.
Gan EY; Chong WS; Tey HL
BioDrugs; 2013 Aug; 27(4):359-73. PubMed ID: 23580094
[TBL] [Abstract][Full Text] [Related]
38. TNF involvement and anti-TNF therapy of reactive and unclassified arthritis.
Meador R; Hsia E; Kitumnuaypong T; Schumacher HR
Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S130-4. PubMed ID: 12463463
[TBL] [Abstract][Full Text] [Related]
39. Th1/Th17 cytokine profiles in patients with reactive arthritis/undifferentiated spondyloarthropathy.
Singh R; Aggarwal A; Misra R
J Rheumatol; 2007 Nov; 34(11):2285-90. PubMed ID: 17937463
[TBL] [Abstract][Full Text] [Related]
40. Reactive arthritis: a favorable 2 year course and outcome, independent of triggering agent and HLA-B27.
Glennås A; Kvien TK; Melby K; Overbøo A; Andrup O; Karstensen B; Thoen JE
J Rheumatol; 1994 Dec; 21(12):2274-80. PubMed ID: 7699628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
